Evaluation of Evidence-Based Dual Antiplatelet Therapy for Secondary Prevention in US Patients With Acute Ischemic Stroke

Post time 2022-5-9 09:34:05

journal：JAMA Internal Medicine

Authors：Ying Xian; Haolin Xu; Eric E. Smith; Gregg C. Fonarow; Deepak L. Bhatt; Lee H. Schwamm; Eric D. Peterson

Published date：2022-5-1

DOI：10.1001/jamainternmed.2022.0323

Article link：http://dx.doi.org/10.1001/jamainternmed.2022.0323

Article Source：American Medical Association (AMA)。

Remark：

Post time 2022-5-9 09:34:06

: This post has been completed
Completed attachments will be deleted within 24 hours.

[JAMA] Evaluation of Evidence-Based Dual Antiplatelet Therapy for Secondary Prevention in US Patients With Acute Ischemic Stroke

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[JAMA] Evaluation of Evidence-Based Dual Antiplatelet Therapy for Secondary Prevention in US Patients With Acute Ischemic Stroke Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[JAMA] Evaluation of Evidence-Based Dual Antiplatelet Therapy for Secondary Prevention in US Patients With Acute Ischemic Stroke